| Product Code: ETC6743959 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The China gemcitabine HCL import market continues to see a diverse range of exporting countries, with the USA, Finland, Japan, India, and Germany leading the way in 2024. The market witnessed a shift from high concentration in 2023 to moderate concentration in 2024, indicating a more balanced competitive landscape. Despite a negative CAGR of -4.74% from 2020 to 2024, the growth rate in 2024 showed a significant decline of -17.66% compared to the previous year. This suggests a challenging environment for gemcitabine HCL importers in China, highlighting the need for strategic adjustments in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Gemcitabine HCL Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Gemcitabine HCL Market Revenues & Volume, 2021 & 2031F |
3.3 China Gemcitabine HCL Market - Industry Life Cycle |
3.4 China Gemcitabine HCL Market - Porter's Five Forces |
3.5 China Gemcitabine HCL Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Gemcitabine HCL Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Gemcitabine HCL Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 China Gemcitabine HCL Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Rising adoption of chemotherapy treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 Presence of alternative treatment options |
4.3.3 High cost associated with gemcitabine HCL treatment |
5 China Gemcitabine HCL Market Trends |
6 China Gemcitabine HCL Market, By Types |
6.1 China Gemcitabine HCL Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Gemcitabine HCL Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Gemcitabine HCL Market Revenues & Volume, By Branded, 2021- 2031F |
6.1.4 China Gemcitabine HCL Market Revenues & Volume, By Generic, 2021- 2031F |
6.2 China Gemcitabine HCL Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Gemcitabine HCL Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.3 China Gemcitabine HCL Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.4 China Gemcitabine HCL Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.5 China Gemcitabine HCL Market Revenues & Volume, By Non-small Cell Lung Carcinoma (NSCLC), 2021- 2031F |
6.2.6 China Gemcitabine HCL Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Gemcitabine HCL Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 China Gemcitabine HCL Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Gemcitabine HCL Market Revenues & Volume, By Cancer Centers, 2021- 2031F |
6.3.4 China Gemcitabine HCL Market Revenues & Volume, By Others, 2021- 2031F |
7 China Gemcitabine HCL Market Import-Export Trade Statistics |
7.1 China Gemcitabine HCL Market Export to Major Countries |
7.2 China Gemcitabine HCL Market Imports from Major Countries |
8 China Gemcitabine HCL Market Key Performance Indicators |
8.1 Number of oncology clinics/hospitals adopting gemcitabine HCL |
8.2 Patient adherence rates to gemcitabine HCL therapy |
8.3 Number of clinical trials using gemcitabine HCL for new indications |
9 China Gemcitabine HCL Market - Opportunity Assessment |
9.1 China Gemcitabine HCL Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Gemcitabine HCL Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Gemcitabine HCL Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 China Gemcitabine HCL Market - Competitive Landscape |
10.1 China Gemcitabine HCL Market Revenue Share, By Companies, 2024 |
10.2 China Gemcitabine HCL Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |